Supermarket Income REIT sees multiple opportunities – Supermarket Income REIT has published its first set of results, covering the 13 month period from incorporation to the end of June 2018. Highlights are: The IPO in July 2017 raised gross proceeds of GBP100 million at an issue price of 100 pence per ordinary share. SUPR’s shares were admitted […]
IBT-investee Sangamo set to disclose gene edited drug data US biotech Sangamo Therapeutics (Nasdaq: SGMO), a mid portfolio but recently enlarged holding for the UK-listed International Biotech Trust (IBT), is set to report the first clinical data from its SB-913 in vivo genome edited therapeutic for Hunter syndrome, at a scientific conference later this week. Sangamo will […]
AZN lupus setback shifts focus to J&J/Lilly drugs The failure last week of the first of two Phase III studies of an AstraZeneca monoclonal antibody in systemic lupus erythematosus (SLE) – and the now assumed lower prospects for success in the second almost identical trial – looks as if it will reduce yet further the industry’s […]
JZ Capital sells Water Treatment Industries to a fund advised by the managers – TWH Water Treatment Industries, Inc. (“Water Treatment Industries”), a subsidiary of one of JZ Capital Partners‘ portfolio companies, Triwater Holdings LLC has agreed to enter into a merger agreement with a newly incorporated subsidiary of DuBois Chemicals, Inc., a company controlled by Resolute Fund […]
IP Group-backed Genomics raises £25m in a Series B Genomics plc, a University of Oxford spin-out backed by UK-based healthcare/tech VC investor IP Group (LSE: IPO), has closed a £25.0m Series B financing round led by the major US biotech, Vertex Pharmaceuticals. Woodford Investment Management – manager of the Woodford Patient Capital Trust (WPCT) – Invesco Perpetual, Oxford […]
Hg, the Manager of HgCapital Trust, has announced that it has made an investment in Allocate Software, which it describes as, “a leading international provider of workforce solutions to the healthcare, defence and maritime sectors”. The terms of the transaction were not disclosed. HgCapital Trust plc will invest approximately £14.0 million in Allocate, alongside other institutional clients of Hg that […]
HICL Infrastructure sells AquaSure desalination stake – HICL Infrastructure Company has entered into an agreement to sell its 9.7% interest in the AquaSure Desalination PPP Project. The value of the group’s investment in AquaSure was increased by approximately 10% in September 2017, in line with a market transaction earlier that year. The disposal price agreed will generate […]
Phaunos now embroiled in Matariki lawsuit – Phaunos Timber Fund says that it has been made aware by Rayonier Canterbury LLC that Rayonier has issued proceedings in the Auckland High Court alleging a breach by Phaunos of confidentiality, notice and consultation obligations in the shareholders agreement between the parties in relation to their respective interests in the Matariki […]
Swiss-listed HBM Healthcare (HBMN) may see a gain from its investment in the private Danish company Y-mAbs Therapeutics, which has filed an S1 registration to raise up to $92m in a Nasdaq IPO. HBM has an 8.2% shareholding in Y-mAbs, which it valued at CHF23m (1.9% of NAV) in its accounts – suggesting the company currently has a CHF280m […]
Biotech trust stock favourite Alnylam Pharmaceuticals (Nasdaq: ALNY) gained more than 16% yesterday after the presentation of ostensibly highly positive clinical trial data on one of its key competitors at a scientific meeting. Alnylam is held by several of the sector’s specialist investment trusts including Biotech Growth (BIOG, 3.6% of NAV) and BB Biotech (BBB, 3.6% of NAV) […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
